● Recruiting

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Condition: Coronary Artery Disease · Multi Vessel Coronary Artery Disease · Sponsor: Bon-Kwon Koo

PhaseN/A

Planned participants500

Who can joinAll sexes, 19 Years to 100 Years

Healthy volunteersNo

About this study

This study is a prospective, multicenter, open-label, observational study to investigate the impact of using drug-coated balloons (DCBs) in the treatment of coronary artery lesions in patients with multivessel coronary artery disease (MVD), as opposed to the default strategy of using only drug-eluting stents (DES). The investigators aim to assess changes in clinical practice towards a hybrid treatment strategy (DES and DCB) and its effects on clinical outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Bon-Kwon Koo, MD, PhD · +82-2-2072-2062 · bkkoo@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Bon-Kwon Koo

Seoul, South Korea

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06104033